Wolfe S, Diven MA, Marciscano AE, Zhou XK, et al. A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT). BMC Cancer 2023;23:923.
PMID: 37777738